Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 1-4 October 2018 5 October 2018NewsHumanPharmacovigilanceResearch and development Fluoroquinolone and quinolone antibiotics: PRAC recommends new restrictions on use following review of disabling and potentially long-lasting side effects 5 October 2018Press releaseHumanPharmacovigilanceResearch and development EMA Management Board: highlights of October 2018 meeting 5 October 2018Press releaseCorporate Boosting the development of medicines for children 2 October 2018NewsHumanPaediatrics EU inspection finds Zhejiang Huahai site non-compliant for manufacture of valsartan: EMA and national authorities considering impact on other active substances produced at the site 28 September 2018Press releaseHuman Regulatory information – adjusted fees for pharmacovigilance applications from 18 October 2018 28 September 2018NewsHumanCorporatePharmacovigilance Harnessing the potential of real world data through a ‘learning healthcare system’ 27 September 2018NewsHumanCorporate EMA launches new corporate website 27 September 2018NewsCorporate EMA to launch new corporate website on 27 September 2018 25 September 2018News Companies stepping up efforts to ensure medicine supply post Brexit 24 September 2018NewsCorporateBrexit 1 … 110 111 112 113 114 Page 114 of 380 115 116 117 118 … 380
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 1-4 October 2018 5 October 2018NewsHumanPharmacovigilanceResearch and development
Fluoroquinolone and quinolone antibiotics: PRAC recommends new restrictions on use following review of disabling and potentially long-lasting side effects 5 October 2018Press releaseHumanPharmacovigilanceResearch and development
EU inspection finds Zhejiang Huahai site non-compliant for manufacture of valsartan: EMA and national authorities considering impact on other active substances produced at the site 28 September 2018Press releaseHuman
Regulatory information – adjusted fees for pharmacovigilance applications from 18 October 2018 28 September 2018NewsHumanCorporatePharmacovigilance
Harnessing the potential of real world data through a ‘learning healthcare system’ 27 September 2018NewsHumanCorporate
Companies stepping up efforts to ensure medicine supply post Brexit 24 September 2018NewsCorporateBrexit